Cancer Family
Hematopoietic and Lymphatic System Neoplasm
CI-CAN-00000022Explore in graph →
Non-malignant4,304 active trials98 approved drugs1,010 evidence items
- NCIt
- C35813
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000022Explore in graph →
Clinical trials
18,827 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00001567 | A Phase II Efficacy Study of Roferon-A in Hairy Cell Leukemia | completed | Phase 2 | 56 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001571 | A Pilot Study of Non-Hodgkin's Lymphoma: Chemotherapy and Blood Levels of Organochlorines | completed | — | 20 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001683 | A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer | completed | Phase 1 | 35 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001689 | A Pharmacokinetic and Pharmacodynamic Study of Vincristine in Children With Leukemia | completed | Phase 1 | 90 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001748 | HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies | completed | Phase 1 | 35 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001750 | Comparing Treatments for Multiple Myeloma | completed | Phase 2 | 32 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001839 | A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome | completed | Phase 2 | 182 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00005785 | Stem Cell (Modified Bone Marrow) Transplantation in HIV-Infected Patients With Blood Cancer | completed | Phase 1 | 30 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00026910 | Analysis of Molecular Markers of Drug Resistance in Tumor Biopsies From Previously Untreated Aggressive Non-Hodgkin's Lymphoma | completed | — | 200 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00047918 | Blood Factors in Mastocytosis and Unexplained Anaphylaxis and Flushing | completed | — | 100 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00066092 | Pegfilgrastim PBPC Mobilization Study | completed | Phase 2 | 41 | AmgenINDUSTRY | 0 | Feb 28, 2008 | clinicaltrials |
| NCT00063713 | VELCADE in Subjects With Relapsed or Refractory Mantle Cell Lymphoma | completed | Phase 2 | 152 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Feb 11, 2008 | clinicaltrials |
| NCT00085696 | VELCADE® (Bortezomib) With Rituximab in Subjects With Relapsed or Refractory Indolent B-Cell Lymphoma | completed | Phase 2 | 66 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Feb 11, 2008 | clinicaltrials |
| NCT00257114 | Evaluation of VELCADE Given as Retreatment to Multiple Myeloma Patients for Efficacy, Safety and Tolerability | completed | Phase 4 | — | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Feb 11, 2008 | clinicaltrials |
| NCT00274248 | MLN518 in Combination With Standard Induction Chemo. for Treatment of Patients With Newly Diagnosed Acute Myelogenous Leukemia | completed | Phase 1 | — | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Feb 11, 2008 | clinicaltrials |
| NCT00599937 | APL93: Timing of CxT and Role of Maintenance | completed | Phase 3 | 576 | Groupe d'etude et de travail sur les leucemies aigues promyelocytairesOTHER | 0 | Jan 24, 2008 | clinicaltrials |
| NCT00090090 | Elsamitrucin (SPI 28090) for Relapsed or Refractory Non-Hodgkin's Lymphoma | completed | Phase 2 | 114 | Spectrum Pharmaceuticals, IncINDUSTRY | 1 | Jan 15, 2008 | clinicaltrials |
| NCT00591526 | A Randomized Trial Assessing the Roles of AraC in Newly Diagnosed APL Promyelocytic Leukemia (APL) | completed | Phase 3 | 250 | Groupe d'etude et de travail sur les leucemies aigues promyelocytairesOTHER | 0 | Jan 14, 2008 | clinicaltrials |
| NCT00044902 | Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma (Low-Grade) | completed | Phase 2 | — | AmgenINDUSTRY | 0 | Dec 28, 2007 | clinicaltrials |
| NCT00116441 | Vaccination in the Peripheral Stem Cell Transplant Setting for Multiple Myeloma | completed | Phase 1 / Phase 2 | 22 | Cell GenesysINDUSTRY | 1 | Dec 24, 2007 | clinicaltrials |
| NCT00116467 | Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia | completed | Phase 2 | 55 | Cell GenesysINDUSTRY | 1 | Dec 24, 2007 | clinicaltrials |
| NCT00086216 | Safety and Efficacy of Atiprimod for Patients With Refractory Multiple Myeloma | completed | Phase 1 / Phase 2 | 30 | Callisto PharmaceuticalsINDUSTRY | 1 | Dec 21, 2007 | clinicaltrials |
| NCT00165347 | Protein Tyrosine Kinases (PTK) in Multiple Myeloma | completed | Phase 2 | 10 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 21, 2007 | clinicaltrials |
| NCT00041990 | Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Accelerated Phase Who Are Refractory to Imatinib Mesylate (Gleevec) | completed | Phase 2 | 40 | Astex Pharmaceuticals, Inc.INDUSTRY | 2 | Dec 17, 2007 | clinicaltrials |
| NCT00001760 | Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy Individuals | completed | — | 40 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Dec 13, 2007 | clinicaltrials |
| NCT00067730 | A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Cancer, Severe Infection Related to Bone Marrow Transplantation | completed | Phase 4 | 7 | Eli Lilly and CompanyINDUSTRY | 1 | Dec 7, 2007 | clinicaltrials |
| NCT00558220 | R-MegaCHOP-ESHAP-BEAM in Patients With High-Risk Aggressive B-Cell Lymphomas(R-MCEB) | completed | Phase 2 | 106 | Czech Lymphoma Study GroupOTHER | 1 | Nov 14, 2007 | clinicaltrials |
| NCT00457288 | Efficacy and Safety of TF002 in Cutaneous Mastocytosis | completed | Phase 2 | 30 | JADO Technologies GmbHINDUSTRY | 1 | Nov 12, 2007 | clinicaltrials |
| NCT00556127 | Rituximab in Addition to Chemotherapy With Autologous Stem Cell Transplantation as Treatment Diffuse Large B-Cell Lymphoma(DLBCL) | completed | Phase 2 | 94 | Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle LeucemieOTHER | 1 | Nov 9, 2007 | clinicaltrials |
| NCT00552825 | Pulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old Children | completed | — | 35 | Sheba Medical CenterOTHER_GOV | 1 | Nov 2, 2007 | clinicaltrials |
| NCT00535912 | Phase III Study Treatment of CLL B and C | completed | Phase 3 | 140 | French Innovative Leukemia OrganisationOTHER | 0 | Nov 1, 2007 | clinicaltrials |
| NCT00536393 | Treatment of Disseminated High Grade Lymphoma | completed | Phase 2 / Phase 3 | 100 | French Innovative Leukemia OrganisationOTHER | 1 | Nov 1, 2007 | clinicaltrials |
| NCT00536458 | Treatment of Localized Low Grade Lymphomas | completed | Phase 3 | 132 | French Innovative Leukemia OrganisationOTHER | 1 | Nov 1, 2007 | clinicaltrials |
| NCT00256191 | Study of TPI 287 Administered Every 21 Days in Patients With Advanced Malignancies | completed | Phase 1 | 45 | Cortice Biosciences, Inc.INDUSTRY | 1 | Oct 15, 2007 | clinicaltrials |
| NCT00044759 | Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or Lymphoma | completed | Phase 3 | — | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 2 | Oct 10, 2007 | clinicaltrials |
| NCT00537550 | Adult ALL Treatment at Diagnosis(LAL2000) | completed | N/A | — | Gruppo Italiano Malattie EMatologiche dell'AdultoOTHER | 1 | Oct 1, 2007 | clinicaltrials |
| NCT00001561 | Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation | completed | Phase 3 | 30 | National Cancer Institute (NCI)NIH | 1 | Sep 24, 2007 | clinicaltrials |
| NCT00062894 | Study of Untreated or Transformed Follicular Non-Hodgkin's Lymphoma With Fission-Derived Iodine I 131 Tositumomab | completed | Phase 1 / Phase 2 | 12 | GlaxoSmithKlineINDUSTRY | 1 | Sep 17, 2007 | clinicaltrials |
| NCT00320827 | Study of CS-1008 in Patients With Advanced Solid Malignancies and Lymphomas (Without Leukemic Component) | completed | Phase 1 | 40 | Daiichi SankyoINDUSTRY | 1 | Sep 11, 2007 | clinicaltrials |
| NCT00061672 | Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory Lymphoma | completed | Phase 2 | 67 | AbbottINDUSTRY | 1 | Aug 15, 2007 | clinicaltrials |
| NCT00514488 | Imatinib Standard Dose (400 mg/Day) Versus Imatinib High Dose (800 mg/Day)(CML022) | completed | Phase 3 | — | University of BolognaOTHER | 1 | Aug 10, 2007 | clinicaltrials |
| NCT00514969 | Protein-Tyrosine Kinase Inhibitor (STI571) for Treatment of Patients With Ph+ Chronic Myeloid Leukemia in Accelerated and Blastic Phase(CML003) | completed | Phase 2 | — | University of BolognaOTHER | 1 | Aug 10, 2007 | clinicaltrials |
| NCT00510926 | Exploratory Study of IMATINIB High Dose in Intermediate Risk Chronic Myeloid Leukemia in Chronic Phase | completed | Phase 2 | 80 | University of BolognaOTHER | 1 | Aug 3, 2007 | clinicaltrials |
| NCT00511303 | Protein-Tyrosine Kinase Inhibitor (STI571) for Treatment of Patients With Ph+ Chronic Myeloid Leukemia | completed | Phase 2 | 200 | University of BolognaOTHER | 0 | Aug 3, 2007 | clinicaltrials |
| NCT00145652 | Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders. | completed | Phase 3 | 66 | Sundsvall HospitalOTHER | 1 | Jul 30, 2007 | clinicaltrials |
| NCT00505141 | Urban Environmental Exposures and Childhood Cancer | completed | — | — | Georgetown UniversityOTHER | 1 | Jul 23, 2007 | clinicaltrials |
| NCT00180115 | AML96 - Risk-Adapted and Randomized Postremission-Therapy for Adult Acute Myeloid Leukemia Patients | completed | Phase 4 | 400 | Technische Universität DresdenOTHER | 1 | Jul 17, 2007 | clinicaltrials |
| NCT00169130 | ACVBP Followed by ASCT in Patients With BCL-2 Positive Diffuse Large B-Cell Lymphoma | completed | Phase 2 / Phase 3 | 300 | Lymphoma Study AssociationOTHER | 2 | Jul 13, 2007 | clinicaltrials |
| NCT00136552 | Study for Newly Diagnosed Follicular Lymphoma Patients With a Large Tumor Burden | completed | Phase 3 | 360 | Lymphoma Study AssociationOTHER | 2 | Jul 3, 2007 | clinicaltrials |
| NCT00344526 | Intensive Versus Conventional Treatment in Patients With Primary Amyloidosis | completed | Phase 3 | 100 | University Hospital, LimogesOTHER | 1 | Jun 28, 2007 | clinicaltrials |
Data updated 23 days agoSource updated Mar 4, 2008source: clinicaltrials